4 documents found, page 1 of 1

Sort by Issue Date

The inflammatory status of soluble microenvironment influences the capacity of ...

Bogéa, Gabriela Muller Reche; Carvalho, Amandda Évelin Silva; Braga, Luma Dayane de Carvalho Filiú; Neves, Francisco de Assis Rocha

The development of immunotherapeutic approaches for the treatment of melanoma requires a better understanding of immunoescape mechanisms of tumor cells and how they interact with other tumor-resident cell types. Here, we evaluated how the conditioned media of resting (rCM) and immune-activated PBMCs (iCM) influence the ability of a metastatic melanoma cell line (MeWo) to control T-cells function. MeWo cells wer...

Date: 2022   |   Origin: Oasisbr

Commentary : mesenchymal stem cells : a new piece in the puzzle of COVID-19 tre...

Carvalho, Juliana Lott; Melgaço Garcez, Emãnuella; Carvalho, Amandda Évelin Silva; Araujo, Felipe Saldanha de

A Commentary on Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment By Saldanha-Araujo F, Melgaço Garcez E, Silva-Carvalho AE and Carvalho JL (2020). Front. Immunol. 11:1563. doi: 10.3389/fimmu.2020.01563.

Date: 2021   |   Origin: Oasisbr

Mesenchymal stem cells : a new piece in the puzzle of COVID-19 treatment

Araujo, Felipe Saldanha de; Melgaço Garcez, Emãnuella; Carvalho, Amandda Évelin Silva; Carvalho, Juliana Lott

COVID-19 is a disease characterized by a strong inflammatory response in severe cases, which fails to respond to corticosteroid therapy. In the context of the current COVID-19 outbreak and the critical information gaps regarding the disease, several different therapeutic strategies are under investigation, including the use of stem cells. In the present manuscript, we provide an analysis of the rationale underl...

Date: 2020   |   Origin: Oasisbr

GVHD-derived plasma as a priming strategy of mesenchymal stem cells

Carvalho, Amandda Évelin Silva; Rodrigues, Leane Perim; Schiavinato, Josiane Lilian; Alborghetti, Marcos Rodrigo; Bettarello, Gustavo

Background: Mesenchymal stem cell (MSC) therapy is an important alternative for GVHD treatment, but a third of patients fail to respond to such therapy. Therefore, strategies to enhance the immunosuppressive potential of MSCs constitute an active area of investigation. Here, we proposed an innovative priming strategy based on the plasma obtained from GVHD patients and tested whether this approach could enhance ...

Date: 2020   |   Origin: Oasisbr

4 Results

Queried text

Refine Results

Author















Date




Document Type


Resource


Subject